| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6041688 | Neuromuscular Disorders | 2011 | 7 Pages |
Abstract
CPEO patients with polymerase gamma-1 mutations reported more functional impairments than those with mitochondrial DNA mutations. Disease impact was however not influenced by most clinical features. The present results help physicians to identify and to treat the factors that influence quality of life in CPEO patients and to provide symptomatic treatment where needed.
Keywords
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Bart W. Smits, Jiske Fermont, Cathérine C.S. Delnooz, Joke S. Kalkman, Gijs Bleijenberg, Baziel G.M. van Engelen,